On August 28, 2020 Immunovia AB (publ) ("Immunovia"), reported that the company will be hosting the second webinar in the series on Immunovia’s IMMray PanCan-d (Press release, Immunovia, AUG 28, 2020, View Source;update-on-launch-activities-301120222.html [SID1234564148]). This second webinar will cover the results of the Commercial Test Model Study (link to pr) and updates on the launch activities.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Event Details:

Immunovia’s IMMray PanCan-d Webinar Series

Webinar No. 2: Commercial Test Model Study & Update on Launch Activities

Date and Time: September 2, 2020 at 16:00 CET

Presenters: Linda Mellby, PhD; Thomas King, MD, PhD, and Laura Chirica, PhD

Immediately after the webinar, the Immunovia team will host a live Q&A session.